Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules

Abstract Background Thyroid nodules affect up to 65% of the population. Although fine needle aspirate (FNA) cytology is the gold standard for diagnosis, 15–30% of results are indeterminate. Molecular testing may aid in the diagnosis of nodules and potentially reduce unnecessary surgery. However, the...

Full description

Bibliographic Details
Published in:	Journal of Otolaryngology - Head and Neck Surgery
Main Authors:	Navjit Dharampal, Kristine Smith, Adrian Harvey, Ralf Paschke, Luke Rudmik, Shamir Chandarana
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-12-01
Subjects:	Cost-effectiveness analysis Molecular testing Afirma Indeterminate thyroid nodule
Online Access:	https://doi.org/10.1186/s40463-022-00604-7

Similar Items

Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules: a meta-analysis
by: Irfan Vardarli, et al.
Published: (2024-06-01)

Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States
by: Michiya Nishino, et al.
Published: (2021-05-01)

Indeterminate thyroid nodules in the era of molecular genomics
by: Sarika N. Rao, et al.
Published: (2020-09-01)

Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology
by: Wiame Potonnier, et al.
Published: (2025-01-01)

Ultrasound radiomics and genomics improve the diagnosis of cytologically indeterminate thyroid nodules
by: Lu Chen, et al.
Published: (2025-02-01)

Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
by: Carolina Ferraz

Intelligent diagnosis of thyroid nodules with AI ultrasound assistance and cytology classification
by: Xiaojuan Cai, et al.
Published: (2025-05-01)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
by: Yuanyuan Zhou, et al.
Published: (2023-09-01)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
by: Cristiane J. Gomes-Lima, et al.
Published: (2020-02-01)

Inter-Reader Agreement of ATA Sonographic Risk in Thyroid Nodules with Bethesda Category III Indeterminate Cytology
by: Maria I. Linares Valderrama, et al.
Published: (2021-04-01)

Diagnostic utility of RAS mutation testing for refining cytologically indeterminate thyroid nodules
by: Isabel R. Riccio, et al.
Published: (2024-02-01)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
by: Ling Zhou, et al.
Published: (2023-01-01)

Evolutionary analysis of indeterminate cytology and risk of malignancy in a thyroid nodule unit
by: Ana Isabel Álvarez-Mancha, et al.
Published: (2024-06-01)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
by: Elizabeth J de Koster, et al.
Published: (2022-07-01)

Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules
by: Jessica O. Pinto, et al.
Published: (2024-03-01)

The Role of Ultrasound as a Predictor of Malignancy in Indeterminate Thyroid Nodules—A Multicenter Study
by: Reem J. Al Argan, et al.
Published: (2025-06-01)

Application of Ultrasonography in Stratifying Malignancy Risk for Indeterminate Thyroid Nodules as per TBSRTC 2023
by: Sofia Guerreiro, et al.
Published: (2024-09-01)

The first Canadian experience with the Afirma® gene expression classifier test
by: Emily Kay-Rivest, et al.
Published: (2017-04-01)

Stratifying Indeterminate Cytology Thyroid Nodules by Combining Thyroid Imaging Reporting and Data Systems (TI-RADS) and The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
by: Steve Marlo Cambe, et al.
Published: (2023-11-01)

Development and validation of mRNA expression-based classifiers to predict low-risk thyroid tumors
by: Allan Golding, et al.
Published: (2025-07-01)

Thyroid nodule with cytological outcome of indeterminate lesion with low risk of malignancy found to be parathyroid adenoma. A case report and minireview of literature
by: Letizia Meomartino, et al.
Published: (2025-02-01)

Ultrasound radiomics models improve preoperative diagnosis and reduce unnecessary biopsies in indeterminate thyroid nodules
by: Lu Chen, et al.
Published: (2025-07-01)

The Incidence of Thyroid Cancer in Bethesda III Thyroid Nodules: A Retrospective Analysis at a Single Endocrine Surgery Center
by: Iyad Hassan, et al.
Published: (2024-05-01)

Thyroid cancer and Hashimoto's thyroiditis in AUS/FLUS nodules: is there a correlation? A retrospective study
by: Saad M. Alqahtani, MD, et al.
Published: (2024-12-01)

Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study
by: Adeel Ahmad Khan, et al.
Published: (2025-09-01)

Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy
by: Chunfang Hu, et al.
Published: (2022-04-01)

Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations
by: Laura Fugazzola, et al.
Published: (2024-05-01)

Weighty Matters: The Obesity–Thyroid Nodule Connection Unveiling the Impact of Obesity on Thyroid Cancer Risk
by: Saad M. Alqahtani, et al.
Published: (2023-09-01)

Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules
by: Grégoire D’Andréa, et al.
Published: (2023-06-01)

Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules
by: Moon Young Oh, et al.
Published: (2024-10-01)

Comparing the diagnostic accuracy of pre-operative genetic testing for thyroid cancer on fine needle aspiration cytology specimens: a systematic review and meta-analysis of diagnostic accuracy
by: Xin Liao, et al.
Published: (2025-10-01)

Clinical Utility of Next-Generation Sequencing-Based Molecular Panel in Thyroid Nodules
by: Hetashvi Gondaliya, et al.
Published: (2025-03-01)

Expert consensus on the evaluation and management of high-risk indeterminate pulmonary nodules
by: Yang Dawei, et al.
Published: (2024-12-01)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
by: Laura Allen, et al.
Published: (2019-03-01)

The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules
by: Shahram Tahvilian, et al.
Published: (2023-06-01)

Multiple Indeterminate pulmonary nodules (IPNs) as independent prognostic indicators in pediatric osteosarcoma: A ten-year retrospective study
by: Yao Weitao, et al.
Published: (2025-06-01)

Role of Ultrasound Elastography and Contrast-Enhanced Ultrasound (CEUS) in Diagnosis and Management of Malignant Thyroid Nodules—An Update
by: Carolina Solomon, et al.
Published: (2025-03-01)

Reporting Thyroid Cytology in a Globalized World
by: Cristina Pizzimenti, et al.
Published: (2021-09-01)

General Patterns and Species-Specific Differences in the Organization of the Tubulin Cytoskeleton in Indeterminate Nodules of Three Legumes
by: Anna B. Kitaeva, et al.
Published: (2021-04-01)

Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis
by: Lorraine W. Lau, et al.
Published: (2021-02-01)